RAPT

RAPT Therapeutics, Inc. Common Stock
$58.02 +0.07%

Recent alerts on RAPT

All signals →
News Agenus (AGEN) Tanks on Colorectal Cancer Study Interim Data - Zacks Investment Research
14d ago
News Lisata (LSTA) Stock Rallies More Than 30% YTD: Here's Why - Zacks Investment Research
14d ago
News Arcutis (ARQT) Stock Rises 31% in the Past Month: Here's Why - Zacks Investment Research
14d ago
News SpringWorks (SWTX) Completes NDA Submission for Mirdametinib
14d ago
News Beam Therapeutics (BEAM) Begins Dosing in Phase I/II AATD Study
14d ago
News Intellia (NTLA) Shares Fall as CFO Glenn Goddard Steps Down
14d ago
News AbbVie (ABBV) Parkinson's Candidate Faces 2nd FDA Rejection
14d ago
News Corcept (CORT) Shares Rise 20% in Three Months: Here's Why
14d ago
News Here's Why You May Invest in Theravance (TBPH) Stock Now
14d ago
News GSK's Filing for Expanded Use of Jemperli Gets EMA Acceptance
14d ago
News Alimera (ALIM) Rises on Merger Deal With ANI Pharmaceuticals
14d ago
News AstraZeneca's (AZN) Truqap Gets EU Nod for Breast Cancer
14d ago
News J&J (JNJ) Seeks Expanded Use of Tremfya for Crohn's Disease
14d ago
News AstraZeneca's (AZN) Truqap Misses Endpoints in TNBC Study
14d ago
News Mirum (MIRM) Soars on Interim Data From Liver Disease Studies
14d ago
News Repligen (RGEN) Promotes CCO, Shares Fall on Leadership Change
14d ago
News AstraZeneca's (AZN) Imfinzi Gets FDA Nod in Expanded Use
14d ago
News Rapt Therapeutics (RAPT) Loses -47.08% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
14d ago
News GSK Expands Pipeline With $950 Million Pulmonary Hypertension Power Play
96d ago
Short volume Short volume 59% of volume (3.5σ)
116d ago
News $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, RAPT, NATH, and LSTA
124d ago
News Why Rapt Therapeutics Stock Soared Today
132d ago
News Forbion Announces Second Exit from Forbion Growth Fund III Following $2.2 Billion Acquisition of RAPT Therapeutics by GSK
132d ago
News $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of RAPT Therapeutics, Inc. (NASDAQ: RAPT)
132d ago
News $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of RAPT Therapeutics, Inc. (NASDAQ: RAPT)
132d ago

Get push alerts for RAPT

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS